MedDRA - 10011401: Crohn's Disease K50
Conditions
Interventions
Group 1: none
non-interventional retrospective oberservational study.
Documentation of historic medical data of Crohn's disease patients successfully treated with mesalazine
Sponsors
FERRING Arzneimittel GmbH
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients with confirmed diagnosis of Crohn's disease - Inital diagnosis after 01.01.2000 - initial treatment of first flare with mesalazine - at least 12 months follow-up - written informed consent
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of prognostic parameters correlation with the response to mesalazine in the first flare of Crohn's disease and during the following maintenance therapy. Documentation of historic medical data in questionnaires | — |
Countries
Germany
Contacts
Public ContactBernd Bokemeyer
Gastroenterologische Schwerpunktpraxis
Outcome results
None listed